Omschrijving
As a treatment for high-risk breast cancer patients, high-dose cyclophosphamide, thiotepa, and carboplatin (CTC) is associated with a drop in cognitive performance over time, new research shows.
Previous reports have shown a drop in cognitive performance among breast cancer survivors treated with cytotoxic therapy, the researchers note in the Journal of the National Cancer Institute.
